KEAP1 and hepatocellular carcinoma: In recent years, various biomarkers have emerged for diagnosing HCC and predicting patient outcome, including glypican 3 and insulin‐like growth factor (IGF)II mRNA 57, Keap1 and pNrf2 58, 3‐microRNA and AFP 59, CXCL1 60, minichromosome maintenance complex ‐7 61, and IGF1 receptor 62, among others.